The Next Wave: “First in Class” or “Best in Class”

• TSE-424 for HRT and Osteoporosis

  • Phase III to Begin 2Q01

• GAR-936 for Antibiotic Resistant Infections

  • Phase III Planned 2Q01

• CCI-779 for Oncology

  • Phase II Began 2Q00

• rPSGL-Ig for Acute Myocardial Infarction

  • Phase II Began 3Q00

• PTP-112 for Type 2 Diabetes

  • Phase I Began 2Q00

Previous slide

Next slide

Back to first slide

View graphic version